Millennium Management’s Allena Pharmaceuticals ALNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-173,798
| Closed | -$33K | – | 7793 |
|
|
2022
Q2 | $33K | Buy |
+173,798
| New | +$26.9K | ﹤0.01% | 6338 |
|
|
2021
Q3 | – | Sell |
-187,431
| Closed | -$244K | – | 7498 |
|
|
2021
Q2 | $244K | Buy |
187,431
+80,625
| +75% | +$97.7K | ﹤0.01% | 5895 |
|
|
2021
Q1 | $148K | Sell |
106,806
-84,569
| -44% | -$141K | ﹤0.01% | 5595 |
|
|
2020
Q4 | $245K | Buy |
+191,375
| New | +$267K | ﹤0.01% | 4692 |
|
|
2020
Q2 | – | Sell |
-371,576
| Closed | -$358K | – | 4774 |
|
|
2020
Q1 | $358K | Sell |
371,576
-181,470
| -33% | -$363K | ﹤0.01% | 3069 |
|
|
2019
Q4 | $1.51M | Buy |
553,046
+68,421
| +14% | +$225K | ﹤0.01% | 2776 |
|
|
2019
Q3 | $1.91M | Buy |
484,625
+158,908
| +49% | +$682K | ﹤0.01% | 2475 |
|
|
2019
Q2 | $1.33M | Buy |
+325,717
| New | +$1.78M | ﹤0.01% | 2635 |
|
|
2018
Q3 | – | Sell |
-219,351
| Closed | -$2.86M | – | 4409 |
|
|
2018
Q2 | $2.86M | Buy |
219,351
+127,272
| +138% | +$1.84M | ﹤0.01% | 2170 |
|
|
2018
Q1 | $1.01M | Buy |
92,079
+69,723
| +312% | +$582K | ﹤0.01% | 2678 |
|
|
2017
Q4 | $225K | Buy |
+22,356
| New | +$276K | ﹤0.01% | 3478 |
|
Other funds holding ALNA
Millennium Management's ALNA Position: Q3 2022 in Review
Millennium Management sold out of Allena Pharmaceuticals (ALNA) in Q3 2022, closing a stake of 173,798 shares — an estimated $33K sold.
Millennium Management first reported a position in ALNA in Q4 2017 and held it in 11 quarters. The position peaked at $2.86M in Q2 2018. 2 funds tracked by Wall St. Rank hold ALNA as of Q3 2022.
- Millennium Management reported no remaining Allena Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
- Millennium Management sold 173,798 Allena Pharmaceuticals shares in Q3 2022, an estimated $33K.
- Millennium Management first reported a position in Allena Pharmaceuticals in Q4 2017 and held it in 11 quarters.
- Millennium Management's Allena Pharmaceuticals position peaked at $2.86M in Q2 2018.
- 2 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2022.
Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.